Search results
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 2 days agoARCT has been the topic of a number of other research reports. Canaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a buy rating ...
Traders Buy Large Volume of Put Options on iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 3 days agoiShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 70,278 put options on ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Dai ichi Life Insurance Company Ltd
ETF DAILY NEWS· 2 days ago(NASDAQ:BIIB – Free Report) by 47.1% during the fourth quarter, according to its most recent...Securities and Exchange Commission (SEC). The firm owned 11,459 shares of the biotechnology ...
Dipal Doshi Sells 1,800 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock
ETF DAILY NEWS· 4 days agoEntrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CEO Dipal Doshi sold 1,800 shares of the business’s stock in a transaction that occurred on Thursday ...
BI Asset Management Fondsmaeglerselskab A S Has $888,000 Position in Axon Enterprise, Inc....
ETF DAILY NEWS· 3 days ago(NASDAQ:AXON – Free Report) by 30.1% during the fourth quarter, according to its most recent Form...
Robeco Institutional Asset Management B.V. Sells 180,219 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 1 day agoRobeco Institutional Asset Management B.V. trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing ...
Jean Jacques Bienaime Purchases 2,000 Shares of Immunome, Inc. (NASDAQ:IMNM) Stock
ETF DAILY NEWS· 2 days agoImmunome, Inc. (NASDAQ:IMNM – Get Free Report) Director Jean Jacques Bienaime bought 2,000 shares of the stock in a transaction dated Tuesday, May 21st.
Celcuity’s (CELC) “Buy” Rating Reaffirmed at HC Wainwright
ETF DAILY NEWS· 6 days agoHC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective ...
Cybin Inc. (NYSE:CYBN) to Post FY2025 Earnings of ($0.09) Per Share, HC Wainwright Forecasts
ETF DAILY NEWS· 7 days agoCybin Inc. (NYSE:CYBN – Free Report) – Equities research analysts at HC Wainwright boosted their...
Abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.48 Per Share
ETF DAILY NEWS· 6 days agoAbrdn Life Sciences Investors (NYSE:HQL – Get Free Report) announced a quarterly dividend on Thursday, May 9th, NASDAQ reports. Shareholders of record on Thursday, May 23rd will be given a dividend ...